Future Perspectives in the Treatment of Polycythemia Vera
John Mascarenhas, MD, and Joe Scandura, MD, PhD, close their discussion by highlighting what to look forward to in the future of polycythemia vera treatment.
Source: onclive.com
Stay updated with breaking news from Iron Availability. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
John Mascarenhas, MD, and Joe Scandura, MD, PhD, close their discussion by highlighting what to look forward to in the future of polycythemia vera treatment.
Key opinion leaders discuss data on the use of ruxolitinib in patients with polycythemia vera.
Drs Joe Scandura and John Mascarenhas discuss their treatment approaches for high-risk patients with polycythemia vera.
Experts review critical trial data in the treatment of patients with polycythemia vera.
Joe Scandura, MD, PhD, summarizes the toxicity profile of interferon therapy in patients with polycythemia vera.